AARTI PHARMALABS
Back to Income Statement
|
AARTI PHARMALABS Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹217 Cr | ₹193 Cr | ₹122 Cr | ₹-0.01 Cr | ₹-0.01 Cr |
What is the latest Consolidated Net Profit of AARTI PHARMALABS ?
Year | Consolidated Net Profit |
---|---|
Mar2025 | ₹217 Cr |
Mar2024 | ₹193 Cr |
Mar2023 | ₹122 Cr |
Mar2022 | ₹-0.01 Cr |
Mar2021 | ₹-0.01 Cr |
How is Consolidated Net Profit of AARTI PHARMALABS Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2025 | ₹217 Cr | 12.10 | |
Mar2024 | ₹193 Cr | 58.28 | |
Mar2023 | ₹122 Cr | Positive | |
Mar2022 | ₹-0.01 Cr | Negative | |
Mar2021 | ₹-0.01 Cr | - |
Compare Consolidated Net Profit of peers of AARTI PHARMALABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI PHARMALABS | ₹8,159.0 Cr | -1.2% | 4.9% | 41.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,451.0 Cr | 2.1% | 0.3% | -9.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,727.0 Cr | -0% | 1.1% | 13.4% | Stock Analytics | |
CIPLA | ₹124,533.0 Cr | -1.1% | -3.2% | -4.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,673.0 Cr | 3.4% | 0.2% | 8.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,629.0 Cr | -0.7% | 2% | 0.7% | Stock Analytics |
AARTI PHARMALABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI PHARMALABS | -1.2% |
4.9% |
41.5% |
SENSEX | 0.5% |
0.4% |
-1.1% |
You may also like the below Video Courses